Drugs / Docetetaxel
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06780085 Comparator | May 2025 → Mar 2032 expected | non-small cell lung carcinoma | Merck Sharp & Dohme LLC | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Docetetaxel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06780085 ↗ |
| Route | Intravenous | “via IV infusion” NCT06780085 ↗ |